Inmed Pharmaceuticals Inc (INM)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Inmed Pharmaceuticals Inc-Aktie (INM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	13.48% 1.2616	1.1117	1.2646	1.2831	1.1726
Cost Of Revenue	66.86% 1.086	0.6508	0.7712	1.0804	0.8831
Gross Profit	61.89% 0.1756	0.4609	0.4934	0.4661	0.2895
Operating Expenses	14.80% 2.3131	2.7149	2.2284	2.5003	2.1338
Benefits Costs and Expenses	8.25% 3.3825	3.6867	2.9425	3.2136	2.8955
Costs And Expenses	8.25% 3.3825	3.6867	2.9425	3.2136	2.8955
Depreciation and Amortization	1.68% 0.0523	0.0532	0.0546	0.0548	0.0548
Operating Income/Loss	34.41% -1.0515	-1.6032	-0.9637	-1.2172	-0.9612
Income/Loss From Continuing Operations Before Tax	17.63% -2.1209	-2.575	-1.6779	-1.9306	-1.7229
Income/Loss From Continuing Operations After Tax	17.63% -2.1209	-2.575	-1.6779	-1.9377	-1.7229
Net Income/Loss	17.63% -2.1209	-2.575	-1.6779	-1.9377	-1.7229
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	55.12% 1.096	0.7065	0.6201	0.6591	9.613
Diluted Average Shares	55.12% 1.096	0.7065	0.6201	0.6591	9.613
Basic Earnings Per Share	46.70% -1.94	-3.64	-2.71	-0.19	-0.18
Diluted Earnings Per Share	46.70% -1.94	-3.64	-2.71	-0.19	-0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

HIMS

$44.39

2.35%

RDY

$13.41

0.90%

ELAN

$22.85

3.16%

VTRS

$10.53

1.64%

NBIX

$141.96

0.87%

UTHR

$438.66

1.52%